Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 8/2018

Open Access 01-08-2018 | Interventional

The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis

Published in: European Radiology | Issue 8/2018

Login to get access

Abstract

Objectives

To study the ratio of ablation zone volume to applied energy in computed tomography (CT)-guided radiofrequency ablation (RFA) and microwave ablation (MWA) in patients with hepatocellular carcinoma (HCC) in a cirrhotic liver and in patients with colorectal liver metastasis (CRLM).

Methods

In total, 90 liver tumors, 45 HCCs in a cirrhotic liver and 45 CRLMs were treated with RFA or with one of two MWA devices (MWA_A and MWA_B), resulting in 15 procedures for each tumor type, per device. Device settings were recorded and the applied energy was calculated. Ablation volumes were segmented on the contrast-enhanced CT scans obtained 1 week after the procedure. The ratio of ablation zone volume in milliliters to applied energy in kilojoules was determined for each procedure and compared between HCC (RHCC) and CRLM (RCRLM), stratified according to ablation device.

Results

With RFA, RHCC and RCRLM were 0.22 mL/kJ (0.14–0.45 mL/kJ) and 0.15 mL/kJ (0.14–0.22 mL/kJ; p = 0.110), respectively. With MWA_A, RHCC was 0.81 (0.61–1.07 mL/kJ) and RCRLM was 0.43 (0.35–0.61 mL/kJ; p = 0.001). With MWA_B, RHCC was 0.67 (0.41–0.85 mL/kJ) and RCRLM was 0.43 (0.35–0.61 mL/kJ; p = 0.040).

Conclusions

With RFA, there was no significant difference in energy deposition ratio between tumor types. With both MWA devices, the ratios were higher for HCCs. Tailoring microwave ablation device protocols to tumor type might prevent incomplete ablations.

Key Points

• HCCs and CRLMs respond differently to microwave ablation
• For MWA, CRLMs required more energy to achieve a similar ablation volume
• Tailoring ablation protocols to tumor type might prevent incomplete ablations
Literature
1.
Curley SA, Izzo F, Delrio P et al (1999) Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg. 230:1–8CrossRefPubMedPubMedCentral
2.
Tanis E, Nordlinger B, Mauer M et al (2014) Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. Eur J Cancer. 50:912–919CrossRefPubMed
3.
Seror O, N’Kontchou G, Nault J-C et al (2016) Hepatocellular carcinoma within Milan criteria: no-touch multibipolar radiofrequency ablation for treatment – long-term results. Radiology. 280:611–621CrossRefPubMed
4.
Kao W-Y, Chiou Y-Y, Hung H-H et al (2011) Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio index. Eur J Gastroenterol Hepatol. 23:528–536PubMed
5.
Lam VW-T, Ng KK, Chok KS-H et al (2008) Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factors. Ann Surg Oncol. 15:782–790CrossRefPubMed
6.
Hof J, Wertenbroek MW, Peeters PM et al (2016) Outcomes after resection and/or radiofrequency ablation for recurrences after treatment of colorectal liver metastases. Br J Surg. 103:1055–1062CrossRefPubMed
7.
Lam VW-T, Ng KK-C, Chok KS-H et al (2008) Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg. 207:20–29CrossRefPubMed
8.
Lu DSK, Raman SS, Limanond P et al (2003) Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol. 14:1267–1274CrossRefPubMed
9.
Kim Y, Rhim H, Cho OK et al (2006) Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol. 59:432–441CrossRefPubMed
10.
Ahmed M, Solbiati L, Brace CL et al (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. Radiology. 273:241–260CrossRefPubMedPubMedCentral
11.
Deshazer G, Merck D, Hagmann M et al (2016) Physical modeling of microwave ablation zone clinical margin variance. Med Phys. 43:1764CrossRefPubMed
12.
McAvoy NC, Semple S, Richards JM et al (2016) Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosis. Aliment Pharmacol Ther. 43:947–954CrossRefPubMed
13.
Van Beers BE, Leconte I, Materne R et al (2001) Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol. 176:667–673CrossRefPubMed
14.
Hashimoto K, Murakami T, Dono K et al (2006) Assessment of the severity of liver disease and fibrotic change: the usefulness of hepatic CT perfusion imaging. Oncol Rep. 16:677–683PubMed
15.
16.
Amabile C, Ahmed M, Solbiati L et al (2017) Microwave ablation of primary and secondary liver tumours: ex vivo, in vivo, and clinical characterisation. Int J Hyperthermia. 33:34–42CrossRefPubMed
17.
Berber E (2016) Laparoscopic microwave thermosphere ablation of malignant liver tumors : an initial clinical evaluation. Surg Endosc. 30:692–698CrossRefPubMed
18.
Simo KA, Tsirline VB, Sindram D et al (2013) Microwave ablation using 915-MHz and 2.45-GHz systems: what are the differences? HPB (Oxford) 15:991–996CrossRef
19.
Liu F-Y, Yu X-L, Liang P et al (2010) Comparison of percutaneous 915 MHz microwave ablation and 2450 MHz microwave ablation in large hepatocellular carcinoma. Int J Hyperthermia. 26:448–455CrossRefPubMed
20.
Zaidi N, Okoh A, Yigitbas H et al (2016) Laparoscopic microwave thermosphere ablation of malignant liver tumors: an analysis of 53 cases. J Surg Oncol. 113:130–134CrossRefPubMed
Metadata
Title
The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis
Publication date
01-08-2018
Published in
European Radiology / Issue 8/2018
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-017-5266-1

Other articles of this Issue 8/2018

European Radiology 8/2018 Go to the issue

Neuro

Monitoring cerebral blood flow change through use of arterial spin labelling in acute ischaemic stroke patients after intra-arterial thrombectomy

Editorial Comment

Editorial Comment: Advances in MRI and PET of the prostate: concurrence or complementarity?

Neuro

Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography

Cardiac

Prediction of infarct size and adverse cardiac outcomes by tissue tracking-cardiac magnetic resonance imaging in ST-segment elevation myocardial infarction

Magnetic Resonance

Vessel architecture in human knee cartilage in children: an in vivo susceptibility-weighted imaging study at 7 T

Interventional

Sequential high intensity focused ultrasound (HIFU) ablation in the treatment of benign multinodular goitre: an observational retrospective study